L. Mortara et al., SELECTION OF VIRUS VARIANTS AND EMERGENCE OF VIRUS ESCAPE MUTANTS AFTER IMMUNIZATION WITH AN EPITOPE VACCINE, Journal of virology, 72(2), 1998, pp. 1403-1410
In this report, we assessed the evolution of the cytotoxic T-lymphocyt
e (CTL) response induced by an epitope vaccine, In two macaques immuni
zed with a mixture of lipopeptides derived from simian immunodeficienc
y virus (SIV) Nef and Gag proteins, CTL responses were directed agains
t the same, single epitope of the Nef protein (amino acids 128 to 137)
presenting an alanine at position 136 (Nef 128-137/136A). However, af
ter 5 months of SIV infection, peripheral blood mononuclear cells from
both macaques lost their ability to be stimulated by autologous SIV-i
nfected cells while still retaining their capacity to generate cytotox
ic responses after specific Nef 128-137/136A peptide stimulation. The
sequences of the pathogenic viral isolate used for the challenge showe
d a mixture of several variants. Within the Nef epitopic sequence from
amino acids 128 to 137, 82% of viral variants expressed the epitopic
peptide Nef 128-137/136A; the remaining variants presented a threonine
at position 136 (Nef 128-137/136T), In contrast, sequence analysis of
cloned proviral DNA obtained from both macaques 5 months after SN cha
llenge showed a different pattern of quasi-species variants; 100% of c
lones presented a threonine at position 136 (Nef 128-137/136T), sugges
ting the disappearance of viral variants with an alanine at this posit
ion under antiviral pressure exerted by Nef 128-137/136A-specific CTLs
. In addition, 12 months after SIV challenge, six: of eight clones fro
m one macaque presented a glutamic acid at position 131 (Nef128-137/13
1E+136T), which was not found in the infecting isolate. Furthermore, C
TLs generated very early after SIV challenge were able to Lyse cells s
ensitized with the Nef 128-137/136A epitope. In contrast, lysis was si
gnificantly less effective or even did not occur when either the selec
ted peptide Nef 128-137/136T or the escape variant peptide Nef 128-137
/131E+136T was used in a target cell sensitization assay. Dose analysi
s of peptides used to sensitize target cells as well as a major histoc
ompatibility complex (MHC)-peptide stability assay suggested that the
selected peptide Nef 128-137/136T has an altered capacity to bind to t
he MHC. These data suggest that CTL pressure leads to the selection of
viral variants and to the emergence of escape mutants and supports th
e fact that immunization should elicit broad CTL responses.